Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosus

Glycobiology

Volumn 23, Issue 1, 2013, Pages 12-22

  Sarter, Kerstin ^a   Janko, Christina ^a   André, Sabine ^b   Muñoz, Luis E ^a   Schorn, Christine ^a   Winkler, Silke ^a   Rech, Jürgen ^a   Kaltner, Herbert ^b   Lorenz, Hanns Martin ^c   Schiller, Martin ^c   Andreoli, Laura ^d   Manfredi, Angelo A ^e   Isenberg, David A ^f   Schett, Georg ^a   Herrmann, Martin ^a   Gabius, Hans Joachim ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF BRESCIA   (Italy)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

antiphospholipid syndrome; autoantibodies; galectins; systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; DOUBLE STRANDED DNA; GALECTIN; GALECTIN 1; GALECTIN 2; GALECTIN 3; GALECTIN 4; GALECTIN 7; GALECTIN 8; OPSONIN; PARAPROTEIN; RHEUMATOID FACTOR;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE DYSREGULATION; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; OPTICAL DENSITY; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BIOLOGICAL MARKERS; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GALECTINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RHEUMATOID FACTOR;

EID: 84870013809     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws120     Document Type: Article

References (61)

1. Andre S, Kaltner H, Lensch M, Russwurm R, Siebert HC, Fallsehr C, Tajkhorshid E, Heck AJ, von Knebel Doeberitz M, Gabius HJ, et al. 2005. Determination of structural and functional overlap/divergence of five prototype galectins by analysis of the growth-regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells. Int J Cancer. 114:46-57. (Pubitemid 40194308)
2. Andre S, Maljaars CE, Halkes KM, Gabius HJ, Kamerling JP. 2007. Discovery of galectin ligands in fully randomized combinatorial one-bead-one-compound (glyco)peptide libraries. Bioorg Med Chem Lett. 17:793-798. (Pubitemid 46108552)
3. Andre S, Sanchez-Ruderisch H, Nakagawa H, Buchholz M, Kopitz J, Forberich P, Kemmner W, Bock C, Deguchi K, Detjen KM, et al. 2007. Tumor suppressor p16INK4a-modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J. 274:3233-3256. (Pubitemid 47028461)
4. Andre S, Specker D, Bovin NV, Lensch M, Kaltner H, Gabius HJ, Wittmann V. 2009. Carbamate-linked lactose: Design of clusters and evidence for selectivity to block binding of human lectins to (neo)glycoproteins with increasing degree of branching and to tumor cells. Bioconj Chem. 20:1716-1728.
5. Andreoli L, Pregnolato F, Burlingame RW, Allegri F, Rizzini S, Fanelli V, Radice A, Corace C, Sinico RA, Meroni PL, et al. 2008. Antinucleosome antibodies in primary antiphospholipid syndrome: A hint at systemic autoimmunity? J Autoimmun. 30:51-57.
6. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315-324. (Pubitemid 18091653)
7. Bassi N, Ghirardello A, Iaccarino L, Zampieri S, Rampudda ME, Atzeni F, Sarzi-Puttini P, Shoenfeld Y, Doria A. 2007. OxLDL/ beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients. Autoimmun Rev. 7:52-58. (Pubitemid 47633392)
8. Beer A, Andre S, Kaltner H, Lensch M, Franz S, Sarter K, Schulze C, Gaipl US, Kern P, Herrmann M, et al. 2008. Human galectins as sensors for apoptosis/necrosis-associated surface changes of granulocytes and lymphocytes. Cytometry A. 73:139-147.
9. Borchers AT, Naguwa SM, Keen CL, Gershwin ME. 2009. The implications of autoimmunity and pregnancy. J Autoimmun. 34:J287-J299.
10. Caberoy NB, Alvarado G, Bigcas JL, Li W. 2012. Galectin-3 is a new MerTK-specific eat-me signal. J Cell Physiol. 227:401-407.
11. Cada Z, Smetana K, Jr, Lacina L, Plzakova Z, Stork J, Kaltner H, Russwurm R, Lensch M, Andre S, Gabius HJ. 2009. Immunohistochemical fingerprinting of the network of seven adhesion/growth-regulatory lectins in human skin and detection of distinct tumour-associated alterations. Folia Biol (Praha). 55:145-152.
12. Caron M, Chadli A, Bladier D, Botti J, Joubert-Caron R. 1994. Lectins in human brain: Some characteristics of 14 kDa beta-galactoside-binding lectin. In: Van Driessche E, Fischer J, Beeckmans S, Bog-Hansen TC, editors. Lectins, biology, biochemistry, clinical biochemistry. Vol. 12. Copenhagen: Textop. p. 227-233.
13. Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N, Atzeni F, Zampieri S, Ghirardello A. 2008. Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev. 8:24-28.
14. Eshkar Sebban L, Ronen D, Levartovsky D, Elkayam O, Caspi D, Aamar S, Amital H, Rubinow A, Golan I, Naor D, et al. 2007. The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. J Immunol. 179:1225-1235.
15. Filer A, Bik M, Parsonage GN, Fitton J, Trebilcock E, Howlett K, Cook M, Raza K, Simmons DL, Thomas AM, et al. 2009. Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways. Arthritis Rheum. 60:1604-1614.
16. Fischer C, Sanchez-Ruderisch H, Welzel M, Wiedenmann B, Sakai T, Andre S, Gabius HJ, Khachigian L, Detjen KM, Rosewicz S. 2005. Galectin-1 interacts with the α5β1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem. 280:37266-37277. (Pubitemid 41587811)
17. Gabius HJ. 2006. Cell surface glycans: The why and how of their functionality as biochemical signals in lectin-mediated information transfer. Crit Rev Immunol. 26:43-79.
18. Gabius HJ, Andre S, Jimenez-Barbero J, Romero A, Solis D. 2011. From lectin structure to functional glycomics: Principles of the sugar code. Trends Biochem Sci. 36:298-313.
19. Gaipl US, Munoz LE, Grossmayer G, Lauber K, Franz S, Sarter K, Voll RE, Winkler T, Kuhn A, Kalden J, et al. 2007. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun. 28:114-121. (Pubitemid 46680499)
20. Giordanengo L, Gea S, Barbieri G, Rabinovich GA. 2001. Anti-galectin-1 autoantibodies in human Trypanosoma cruzi infection: Differential expression of this beta-galactoside-binding protein in cardiac Chagas' disease. Clin Exp Immunol. 124:266-273. (Pubitemid 32587611)
21. Hartmann TB, Thiel D, Dummer R, Schadendorf D, Eichmuller S. 2004. SEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma. Br J Dermatol. 150:252-258. (Pubitemid 38352462)
22. He L, Andre S, Siebert HC, Helmholz H, Niemeyer B, Gabius HJ. 2003. Detection of ligand-and solvent-induced shape alterations of cell-growthregulatory human lectin galectin-1 in solution by small angle neutron and x-ray scattering. Biophys J. 85:511-524. (Pubitemid 36753655)
23. Hochberg MC. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40:1725.
24. Janko C, Schorn C, Grossmayer GE, Frey B, Herrmann M, Gaipl US, Munoz LE. 2008. Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE). Autoimmun Rev. 8:9-12.
25. Jensen-Jarolim E, Neumann C, Oberhuber G, Gscheidlinger R, Neuchrist C, Reinisch W, Zuberi RI, Penner E, Liu FT, Boltz-Nitulescu G. 2001. Anti-Galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries. J Clin Immunol. 21:348-356. (Pubitemid 33015805)
26. Kallenberg CG. 2008. Anti-C1q autoantibodies. Autoimmun Rev. 7:612-615.
27. Kaltner H, Gabius HJ. 2012. A toolbox of lectins for translating the sugar code: The galectin network in phylogenesis and tumors. Histol Histopathol. 27:397-416.
28. Karlsson A, Christenson K, Matlak M, Bjorstad A, Brown KL, Telemo E, Salomonsson E, Leffler H, Bylund J. 2009. Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils. Glycobiology. 19:16-20.
29. Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, Yoshida N, Nakamura T, Hirashima M. 2003. Galectin-9 induces apoptosis through the calcium-calpain- caspase-1 pathway. J Immunol. 170:3631-3636. (Pubitemid 36359232)
30. Kubler D, Hung CW, Dam TK, Kopitz J, Andre S, Kaltner H, Lohr M, Manning JC, He L, Wang H, et al. 2008. Phosphorylated human galectin-3: Facile large-scale preparation of active lectin and detection of structural changes by CD spectroscopy. Biochim Biophys Acta. 1780:716-722.
31. Ledeen RW, Wu G, Andre S, Bleich D, Huet G, Kaltner H, Kopitz J, Gabius HJ. 2012. Beyond glycoproteins as galectin counterreceptors: Effector T cell growth control of tumors via ganglioside GM1. Ann N Y Acad Sci. 1253:206-221.
32. Lensch M, Lohr M, Russwurm R, Vidal M, Kaltner H, Andre S, Gabius HJ. 2006. Unique sequence and expression profiles of rat galectins-5 and-9 as a result of species-specific gene divergence. Int J Biochem Cell Biol. 38:1741-1758. (Pubitemid 43947656)
33. Lim Y, Lee DY, Lee S, Park SY, Kim J, Cho B, Lee H, Kim HY, Lee E, Song YW, et al. 2002. Identification of autoantibodies associated with systemic lupus erythematosus. Biochem Biophys Res Commun. 295:119-124. (Pubitemid 34743785)
34. Liu FT. 2005. Regulatory roles of galectins in the immune response. Int Arch Allergy Immunol. 136:385-400.
35. Liu FT, Yang RY, Hsu DK. 2012. Galectins in acute and chronic inflammation. Ann N Y Acad Sci. 1253:80-91.
36. Lutomski D, Caron M, Bourin P, Lefebure C, Bladier D, Joubert-Caron R. 1995. Purification and characterization of natural antibodies that recognize a human brain lectin. J Neuroimmunol. 57:9-15.
37. Lutomski D, Joubert-Caron R, Lefebure C, Salama J, Belin C, Bladier D, Caron M. 1997. Anti-galectin-1 autoantibodies in serum of patients with neurological diseases. Clin Chim Acta. 262:131-138. (Pubitemid 27241384)
38. Massardo L, Metz C, Pardo E, Mezzano V, Babul M, Jarpa E, Guzman AM, Andre S, Kaltner H, Gabius HJ, et al. 2009. Autoantibodies against galectin-8: Their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation. Lupus. 18:539-546.
39. Meroni PL, Shoenfeld Y. 2008. Predictive, protective, orphan autoantibodies: The example of anti-phospholipid antibodies. Autoimmun Rev. 7:585-587.
40. Montiel JL, Monsivais-Urenda A, Figueroa-Vega N, Moctezuma JF, Burgos-Vargas R, Gonzalez-Amaro R, Rosenstein Y. 2010. Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus. Scand J Rheumatol. 39:50-57.
41. Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. 2010. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol. 6:280-289.
42. Ohshima S, Kuchen S, Seemayer CA, Kyburz D, Hirt A, Klinzing S, Michel BA, Gay RE, Liu FT, Gay S, et al. 2003. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum. 48:2788-2795. (Pubitemid 37280607)
43. Praprotnik S, Sodin-Semrl S, Tomsic M, Shoenfeld Y. 2008. The curiously suspicious: Infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun. 30:37-41.
44. Purkrabkova T, Smetana K, Jr., Dvorankova B, Holikova Z, Bock C, Lensch M, Andre S, Pytlik R, Liu FT, Klima J, et al. 2003. New aspects of galectin functionality in nuclei of cultured bone marrow stromal and epidermal cells: Biotinylated galectins as tool to detect specific binding sites. Biol Cell. 95:535-545. (Pubitemid 37461484)
45. Rahman A, Isenberg DA. 2008. Systemic lupus erythematosus. N Engl J Med. 358:929-939. (Pubitemid 351397092)
46. Romero MD, Muino JC, Bianco GA, Ferrero M, Juarez CP, Luna JD, Rabinovich GA. 2006. Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis. Invest Ophthalmol Vis Sci. 47:1550-1556. (Pubitemid 46780764)
47. Saal I, Nagy N, Lensch M, Lohr M, Manning JC, Decaestecker C, Andre S, Kiss R, Salmon I, Gabius HJ. 2005. Human galectin-2: Expression profiling by RT-PCR/immunohistochemistry and its introduction as a histochemical tool for ligand localization. Histol Histopathol. 20:1191-1208. (Pubitemid 41489164)
48. Sanchez-Ruderisch H, Detjen KM, Welzel M, Andre S, Fischer C, Gabius HJ, Rosewicz S. 2011. Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptor alpha5beta1-integrin. Cell Death Differ. 18:806-816.
49. Sarter K, Andre S, Kaltner H, Lensch M, Schulze C, Urbonaviciute V, Schett G, Herrmann M, Gabius HJ. 2009. Detection and chromatographic removal of lipopolysaccharide in preparations of multifunctional galectins. Biochem Biophys Res Commun. 379:155-159.
50. Saussez S, de Leval L, Decaestecker C, Sirtaine N, Cludts S, Duray A, Chevalier D, Andre S, Gabius HJ, Remmelink M, et al. 2010. Galectin fingerprinting in Warthin's tumors: Lectin-based approach to trace its origin? Histol Histopathol. 25:541-550.
51. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, Old LJ. 1998. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer. 76:652-658. (Pubitemid 28243936)
52. Schwartz-Albiez R. 2009. Inflammation and glycosciences. In: Gabius HJ, editor. The Sugar Code. Fundamentals of glycosciences.Weinheim:Wiley-VHC. p. 447-467.
53. Seki M, Oomizu S, Sakata KM, Sakata A, Arikawa T, Watanabe K, Ito K, Takeshita K, Niki T, Saita N, et al. 2008. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol. 127:78-88.
54. Seki M, Sakata KM, Oomizu S, Arikawa T, Sakata A, Ueno M, Nobumoto A, Niki T, Saita N, Ito K, et al. 2007. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum. 56:3968-3976. (Pubitemid 350262324)
55. Sturm A, Lensch M, Andre S, Kaltner H, Wiedenmann B, Rosewicz S, Dignass AU, Gabius HJ. 2004. Human galectin-2: Novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol. 173:3825-3837. (Pubitemid 39280745)
56. Suarez-Alvarez B, Garcia Suarez MM, Arguelles ME, Sampedro A, Alvarez Marcos C, Mira E, Van den Brul FA, Liu FT, Chowdhury PS, de los Toyos Jr. 2001. Circulating IgG response to stromelysin-3, collagenase-3, galectin-3 and mesothelin in patients with pharynx/larynx squamous cell carcinoma. Anticancer Res. 21:3677-3684. (Pubitemid 34224283)
57. Suk K, Hwang DY, Lee MS. 1999. Natural autoantibody to galectin-9 in normal human sera. J Clin Immunol. 19:158-165. (Pubitemid 29318689)
58. Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E. 2009. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Autoimmunity. 42:497-506.
59. Tincani A, Andreoli L, Chighizola C, Meroni PL. 2009. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus. Autoimmunity. 42:257-259.
60. Tsutsumi A, Takahashi R, Sumida T. 2005. Mannose binding lectin: Genetics and autoimmune disease. Autoimmun Rev. 4:364-372. (Pubitemid 41080073)
61. Wang J, Lu ZH, Gabius HJ, Rohowsky-Kochan C, Ledeen RW, Wu G. 2009. Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: Possible role in suppressing experimental autoimmune encephalomyelitis. J Immunol. 182:4036-4045.